These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8128448

  • 1. Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.
    Rijken DC, de Munk GA, Jie AF.
    Thromb Haemost; 1993 Nov 15; 70(5):867-72. PubMed ID: 8128448
    [Abstract] [Full Text] [Related]

  • 2. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE, Smith CJ.
    Arch Biochem Biophys; 1993 Nov 15; 307(1):138-45. PubMed ID: 8239651
    [Abstract] [Full Text] [Related]

  • 3. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM, Gamba C, Kordich LC.
    Thromb Res; 2007 Nov 15; 120(5):745-52. PubMed ID: 17270255
    [Abstract] [Full Text] [Related]

  • 4. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T, Yamauchi T, Horie M, Nagumo T, Suzuki H.
    Thromb Res; 2000 Sep 15; 99(6):623-34. PubMed ID: 10974349
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA, Groeneveld E, Rijken DC.
    Thromb Haemost; 1993 Sep 01; 70(3):481-5. PubMed ID: 8259553
    [Abstract] [Full Text] [Related]

  • 6. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M, Cavallo LG, Agnelli G, Mele A, Bürgi R, Heim J, Semeraro N.
    Thromb Haemost; 1993 May 03; 69(5):466-72. PubMed ID: 8391727
    [Abstract] [Full Text] [Related]

  • 7. Effect of oversulfation on the chemical and biological properties of chondroitin-4-sulfate.
    Carranza YE, Durand-Rougley C, Doctor V.
    Blood Coagul Fibrinolysis; 2008 Sep 03; 19(6):483-7. PubMed ID: 18685430
    [Abstract] [Full Text] [Related]

  • 8. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D, Lijnen HR.
    Thromb Haemost; 1995 Jul 03; 74(1):167-71. PubMed ID: 8578451
    [Abstract] [Full Text] [Related]

  • 9. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
    Stassen JM, Juhan-Vague I, Alessi MC, De Cock F, Collen D.
    Thromb Haemost; 1987 Oct 28; 58(3):947-50. PubMed ID: 2829381
    [Abstract] [Full Text] [Related]

  • 10. Alcohol-induced up-regulation of fibrinolytic activity and plasminogen activators in human monocytes.
    Tabengwa EM, Wheeler CG, Yancey DA, Grenett HE, Booyse FM.
    Alcohol Clin Exp Res; 2002 Aug 28; 26(8):1121-7. PubMed ID: 12198385
    [Abstract] [Full Text] [Related]

  • 11. A collaborative study to establish a standard for high molecular weight urinary-type plasminogen activator (HMW/u-PA).
    Gaffney PJ, Heath AB.
    Thromb Haemost; 1990 Nov 30; 64(3):398-401. PubMed ID: 2128969
    [Abstract] [Full Text] [Related]

  • 12. Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom.
    Sanchez EF, Santos CI, Magalhaes A, Diniz CR, Figueiredo S, Gilroy J, Richardson M.
    Arch Biochem Biophys; 2000 Jun 01; 378(1):131-41. PubMed ID: 10871053
    [Abstract] [Full Text] [Related]

  • 13. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar 01; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The activation mechanism of human plasminogen.
    Rickli EE.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):386-95. PubMed ID: 128150
    [No Abstract] [Full Text] [Related]

  • 16. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
    Ugwu F, Lemmens G, Collen D, Lijnen HR.
    Thromb Haemost; 1999 Sep 15; 82(3):1127-31. PubMed ID: 10494776
    [Abstract] [Full Text] [Related]

  • 17. [Molecular interactions during fibrinolysis. Search for new plasminogen activators].
    Maksimenko AV.
    Mol Biol (Mosk); 1995 Sep 15; 29(1):38-60. PubMed ID: 7723763
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR, van den Berg BM, Moestrup SK, Pannekoek H, van Zonneveld AJ.
    Thromb Haemost; 1998 Nov 15; 80(5):822-8. PubMed ID: 9843178
    [Abstract] [Full Text] [Related]

  • 19. Interaction of reteplase with heparin. A comparison between reteplase and alteplase.
    Rijken DC, Jie AF.
    Blood Coagul Fibrinolysis; 1996 Jul 15; 7(5):561-6. PubMed ID: 8874867
    [Abstract] [Full Text] [Related]

  • 20. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW.
    Blood Coagul Fibrinolysis; 1993 Feb 15; 4(1):123-5. PubMed ID: 8457639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.